Pipelines
Breast Carcinoma
Triple Negative, Stage 2.
Stage one in vitro research in China resulted in proof of concept. Now starting Stage 2, translation research using lanthanide/polyphenolic compounds targeting Fe2/3, Cu2+, Ca2+ and PO4; primary, metastasis and recurrence.
Ovarian Carcinoma
HGSO, CCOC, Endometrioid Stage 1.
New research in three subtypes using actinide radionuclides and polyphenols targeting primary tumour cells, metastasis, recurrence and alternative nutrients, serine, glycine and arginine. The role of hyaluronic acid. Correlation with endometriosis.
Colorectal Carcinoma
CRC, Stage 1.
New research using lanthanide/polyphenolic compounds targeting Fe2/3 driving F. nucleatum, C. dificile, S. enterica and B. Fragilis in tumour progression. Consideration of amino acids leucine, valine, tryptophan in HCC metastasis.
Pancreatic Carcinoma
PDAC Stage 1.
New research using actinide radionuclides, lanthanide compounds and polyphenols targeting Fe2/3 and Ca2+ mediated F. nucleatum, alternate nutrients serine, glycine and asparagine. Role of hyaluronic acid. Triptolide in metastasis and recurrence inhibition.
Endometriosis/Adenomyosis
Stage 2.
Lanthanide compounds with flavonoid/stilbene polyphenols to inhibit uncontrolled cell growth in the peritoneum and endometrium.